X

Trial Profile

Investigation of availability of solifenacin succinate on effect insufficiency cases by b3 receptor agonist -Switching study from mirabegron to solifenacin-

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2016

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Solifenacin (Primary)
Indications Overactive bladder
Focus Therapeutic Use
Acronyms WATCH

Most Recent Events

16 Sep 2016 Results (n=27) presented at the 46th Annual Meeting of the International Continence Society
11 Apr 2016 Status changed from active, no longer recruiting to completed.
02 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com